HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)
2020
AbstractPCOS treatment should be based on pathophysiology. High-mobility-group-box-1 (HMGB1) was shown to increase in PCOS patients as a consequence of reduced cystic-fibrosis-transmembrane-conduct...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
65
References
6
Citations
NaN
KQI